| Q46859780 | Abnormalities of sarcoplasmic reticulum Ca2+ mobilization in aortic smooth muscle cells from streptozotocin-induced diabetic rats |
| Q36827279 | Adrenergic and calcium modulation of the heart in stress: from molecular biology to function. |
| Q34280120 | Alteration of second messengers during acute cerebral ischemia - adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein |
| Q36358067 | Cerebellar regulation mechanisms learned from studies on GluRdelta2. |
| Q21092490 | Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans |
| Q92354437 | Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA) |
| Q43942870 | Emergence of a functional coupling between inositol-1,4,5-trisphosphate receptors and calcium channels in developing neocortical neurons. |
| Q47335940 | First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning |
| Q48193513 | Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality |
| Q37290734 | Inositol 1,4,5- trisphosphate receptor function in Drosophila insulin producing cells |
| Q30437824 | Localized expression of an Ins(1,4,5)P3 receptor at the myoendothelial junction selectively regulates heterocellular Ca2+ communication |
| Q37204082 | MRI shows a region-specific pattern of atrophy in spinocerebellar ataxia type 2. |
| Q36354408 | Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE-/- mice on a Western d |
| Q38459199 | Molecular approaches for manipulating astrocytic signaling in vivo. |
| Q28507993 | Myosin-Va transports the endoplasmic reticulum into the dendritic spines of Purkinje neurons |
| Q51893612 | Neuronal transport: myosins pull the ER. |
| Q37294792 | Orais and STIMs: physiological mechanisms and disease |
| Q28593098 | Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis |
| Q24314365 | Phospholipid scramblase 1 binds to the promoter region of the inositol 1,4,5-triphosphate receptor type 1 gene to enhance its expression |
| Q39159540 | Prodromal spinocerebellar ataxia type 2: Prospects for early interventions and ethical challenges |
| Q52908233 | Proteolytic fragmentation of inositol 1,4,5-trisphosphate receptors: a novel mechanism regulating channel activity? |
| Q41368463 | Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome |
| Q35125192 | SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia |
| Q44492927 | Spinocerebellar ataxia type 15 (sca15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant |
| Q36691003 | TLR3-/4-Priming Differentially Promotes Ca(2+) Signaling and Cytokine Expression and Ca(2+)-Dependently Augments Cytokine Release in hMSCs |
| Q43193906 | Type 3 inositol 1,4,5-trisphosphate receptor negatively regulates apoptosis during mouse embryonic stem cell differentiation |